Symmerty Surgical Launches Uterine Compression Clamp

Symmetry Medical Inc. announced today it has launched the Staggs Uterine Compression Clamp through its hospital direct medical device segment, Symmetry Surgical, Inc.

Innovative New Product Designed to Mechanically Compress the Myometrium During Postpartum Uterine Atony After a Routine Cesarean Section

WARSAW, Ind. , June 11, 2012 (GLOBE NEWSWIRE) --Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants and sterilization cases and trays, announced today it has launched the Staggs Uterine Compression Clamp through its hospital direct medical device segment, Symmetry Surgical, Inc.

The Staggs Uterine Compression Clamp is designed for hands-free mechanical compression of the myometrium during postpartum uterine atony following a routine cesarean section. It can be quickly applied to the external portion of the myometrium to address postpartum uterine atony.

The Staggs Uterine Compression Clamp incorporates Babcock-style jaws that stabilize the clamp to secure the myometrium. Silicone jaw inserts aid in the protection of the tissue while securing the fundus of the myometrium. An optional silicone compression belt is designed as an easily adjustable component to enable rapid identification and deployment. The adaptability of the clamp allows the surgeon and their operating room staff to maintain focus on addressing the postpartum uterine atony through application of longitudinal compression of the myometrium with the silicone compression belt.

"Mechanical compression of the myometrium using the Staggs Uterine Compression Clamp allows the surgeon to immediately slow the rate of hemorrhage and significantly lower total blood loss during both routine c-sections and postpartum uterine atony. The clamp is simple, effective and reusable. I hope it will make all c-sections safer and decrease maternal morbidity and mortality worldwide," said Dr. Stephen M. Staggs, M.D., inventor of the Staggs Uterine Compression Clamp.

The market for the Staggs Uterine Compression Clamp is substantial. In 2009 there were 4,130,665 births among U.S. residents, with cesarean deliveries representing 32.9% or 1,353,572 of the total.

Chris Huntington, Chief Operating Officer of Symmetry Surgical, added, "The Staggs Uterine Compression Clamp is the latest in Symmetry Surgical's continuing efforts to address the unmet needs of surgeons and their patients with innovative, clinically relevant designs."

About Symmetry Surgical Inc.
Symmetry Surgical is dedicated to developing quality surgical instruments that meet the needs of clinicians and help improve the lives of patients. Our portfolio brings together the product lines of Specialty Surgical Instrumentation (SSi), Olsen Medical and the recently acquired surgical instruments division Codman & Shurtleff, Inc. Our well-known brands include BOOKWALTER®, GREENBERG™, RILEY™, OLSEN™, ULTRA™, QUAD-LOCK™, FLASHPAK™, RAPIDCLEAN®, OPTI-LENGTH®, CLASSIC® and CLASSIC PLUS®. Headquartered in Nashville, Symmetry Surgical is a wholly owned subsidiary of Symmetry Medical Inc (NYSE:SMA).

About Symmetry Medical Inc.
Symmetry Medical Inc. is a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company's thousands of Teammates provide design, development and worldwide production capabilities for these products to customers in the orthopedic industry, other medical device markets, and specialized non-healthcare markets. Symmetry's trusted reputation and brands, broad Intellectual Property portfolio and commitment to innovation enable it to collaborate with hundreds of global medical device manufacturers as well as thousands of hospitals to provide solutions for today's needs and tomorrow's growth.

Forward-Looking Statements
Statements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forwardlooking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC , which are available on the SEC's Web site at www.sec.gov.

Symmetry Medical Inc.
Fred L. Hite
Senior Vice President
Chief Financial Officer
(574) 371-2218

Investors / Media:
The Ruth Group
Zack Kubow / Lisa Cook
(646) 536-7020 / 7012